MetroPCS RETAINS Mkt Perform and 3 Analyst-Reiterated Ratings to Notice

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on July 30th.

ISIS Pharm (NASDAQ:ISIS): Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $11 to $17.

Don’t Miss: Samsung’s Smartphones Are OUTSELLING Apple’s iPhone.

Palomar Medical (NASDAQ:PMTI): Needham reiterated its rating of Buy for this company and changed its price target from $20 to $11.

MetroPCS (NYSE:PCS): FBR Capital reiterated its rating of Mkt Perform for this company and changed its price target from $14 to $11.

Concur Tech (NASDAQ:CNQR): Oppenheimer reiterated its rating of Outperform for this company and changed its price target from $70 to $73.

Don’t Miss: Wall Street Brief: HSBC Beats the Street, Apple vs. Samsung KICKS OFF.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

More from The Cheat Sheet